These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 14725035

  • 1. [Treatment of hypertension in a clinical trial. Depot alpha 1 blocker simplifies dosing].
    Sauerbrey-Wullkopf N, Leverkus F.
    MMW Fortschr Med; 2003 Nov 20; 145(47):54. PubMed ID: 14725035
    [No Abstract] [Full Text] [Related]

  • 2. Effect of doxazosin gastrointestinal therapeutic system as third-line antihypertensive therapy on blood pressure and lipids in the Anglo-Scandinavian Cardiac Outcomes Trial.
    Chapman N, Chang CL, Dahlöf B, Sever PS, Wedel H, Poulter NR, ASCOT Investigators.
    Circulation; 2008 Jul 01; 118(1):42-8. PubMed ID: 18559700
    [Abstract] [Full Text] [Related]

  • 3. Doxazosin in metabolically complicated hypertension.
    Dell'Omo G, Penno G, Del Prato S, Pedrinelli R.
    Expert Rev Cardiovasc Ther; 2007 Nov 01; 5(6):1027-35. PubMed ID: 18035918
    [Abstract] [Full Text] [Related]

  • 4. Doxazosin: safety and efficacy in the treatment of resistant arterial hypertension.
    Ceral J, Solar M.
    Blood Press; 2009 Nov 01; 18(1-2):74-7. PubMed ID: 19353415
    [Abstract] [Full Text] [Related]

  • 5. New alpha 1-adrenergic blocker offers once-daily dosing.
    Geriatrics; 1991 Jan 01; 46(1):20, 23. PubMed ID: 1670634
    [No Abstract] [Full Text] [Related]

  • 6. [Alpha-blockers in therapy of arterial hypertension. No longer the drug of first choice].
    Faulhaber HD.
    MMW Fortschr Med; 2001 May 31; 143(22):30-2. PubMed ID: 11460395
    [No Abstract] [Full Text] [Related]

  • 7. [Depot calcium antagonist. General practice study confirms good tolerance].
    MMW Fortschr Med; 2003 Jan 30; 145(5):56. PubMed ID: 12619222
    [No Abstract] [Full Text] [Related]

  • 8. Should patients with benign prostatic hypertrophy stop taking doxazosin in the light of the ALLHAT study?
    Cheng TO.
    Int J Cardiol; 2006 Feb 15; 107(2):275-6. PubMed ID: 16412808
    [No Abstract] [Full Text] [Related]

  • 9. The bedtime administration of doxazosin controls morning hypertension and albuminuria in patients with type-2 diabetes: evaluation using home-based blood pressure measurements.
    Kamoi K, Ikarashi T.
    Clin Exp Hypertens; 2005 May 15; 27(4):369-76. PubMed ID: 15921073
    [Abstract] [Full Text] [Related]

  • 10. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar 15; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 11. An alpha-adrenergic blocker titrated by self-measured blood pressure recordings lowered blood pressure and microalbuminuria in patients with morning hypertension: the Japan Morning Surge-1 Study.
    Kario K, Matsui Y, Shibasaki S, Eguchi K, Ishikawa J, Hoshide S, Ishikawa S, Kabutoya T, Schwartz JE, Pickering TG, Shimada K, Japan Morning Surge-1 (JMS-1) Study Group.
    J Hypertens; 2008 Jun 15; 26(6):1257-65. PubMed ID: 18475166
    [Abstract] [Full Text] [Related]

  • 12. The clinical efficacy and tolerability of doxazosin standard and gastrointestinal therapeutic system for benign prostatic hyperplasia.
    Fitzpatrick JM, Desgrandchamps F.
    BJU Int; 2005 Mar 15; 95(4):575-9. PubMed ID: 15705083
    [Abstract] [Full Text] [Related]

  • 13. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y, Tsuchihashi T, Onaka U, Eto K, Ueno M.
    Hypertens Res; 2007 Apr 15; 30(4):301-6. PubMed ID: 17541208
    [Abstract] [Full Text] [Related]

  • 14. Clinical ease of using doxazosin in BPH patients with and without hypertension.
    Steers WD, Kirby RS.
    Prostate Cancer Prostatic Dis; 2005 Apr 15; 8(2):152-7. PubMed ID: 15711605
    [Abstract] [Full Text] [Related]

  • 15. [In what sense are alpha 1-receptor blockers as first choice agents in treatment of hypertension suitable?].
    Düsing R.
    Internist (Berl); 1996 Sep 15; 37(9):941. PubMed ID: 8964692
    [No Abstract] [Full Text] [Related]

  • 16. Long-term follow-up study to evaluate the efficacy and safety of the doxazosin gastrointestinal therapeutic system in patients with benign prostatic hyperplasia with or without concomitant hypertension.
    Chung BH, Hong SJ.
    BJU Int; 2006 Jan 15; 97(1):90-5. PubMed ID: 16336335
    [Abstract] [Full Text] [Related]

  • 17. Beneficial effects of extended-release doxazosin and doxazosin standard on sexual health.
    Kaplan SA, DE Rose AF, Kirby RS, O'leary MP, McVary KT.
    BJU Int; 2006 Mar 15; 97(3):559-66. PubMed ID: 16469026
    [Abstract] [Full Text] [Related]

  • 18. In vivo administration of doxazosin in rats highly decreases serum circulating levels of testosterone through a mechanism involving the testicular renin-angiotensin system.
    de la Chica-Rodríguez S, Cortés-Denia P, Ramírez-Expósito MJ, de Saavedra JM, Sánchez-Agesta R, Pérez Mdel C, Martínez-Martos JM.
    Int J Androl; 2008 Jun 15; 31(3):364-70. PubMed ID: 17573849
    [Abstract] [Full Text] [Related]

  • 19. [Alpha-1 blockers for therapy of essential hypertension. 2 clinical studies with bunazosin].
    Meyer U, Schmidt J.
    Fortschr Med; 1998 May 20; 116(14):43-4. PubMed ID: 9648395
    [No Abstract] [Full Text] [Related]

  • 20. [Value of combination therapy in treatment of hypertension].
    Kreutz R.
    Krankenpfl J; 2005 May 20; 43(7-10):255. PubMed ID: 16515324
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.